Mumbai, Sept. 18 -- Gujarat Themis Biosyn announced the completion of the acquisition of 100% equity shareholding in MicroBiopharm Japan Co. (MBJ), Japan, through Themis Biosyn Japan, a wholly owned subsidiary incorporated in Japan.

Published by HT Digital Content Services with permission from Capital Market....